Women turn to testosterone for low sex drive as doctors confront treatment ‘experimentation’

Dr. Kudzai Dombo documented insurance denials and variable dosing practices among women seeking testosterone therapy, according to reporting on the treatment. The FDA has begun reviewing testosterone access protocols for women experiencing low sexual desire. Current testosterone products approved by the FDA are labeled for male use only, though some physicians prescribe them off-label for women. Insurance companies frequently deny coverage for off-label testosterone prescriptions, and treatment dosing varies among providers due to the absence of standardized female dosing guidelines.

Next story